Quarry LP’s KalVista Pharmaceuticals KALV Stock Holding History

Quarry LP’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,750	Closed	-$679K	–	2478
2026 Q1	$679K	Buy	+33,750	New	+$544K	0.12%	126
2025 Q3	–	Sell	-16,796	Closed	-$190K	–	2341
2025 Q2	$190K	Buy	16,796 +8,396	+100%	+$103K	0.04%	372
2025 Q1	$96.9K	Buy	+8,400	New	+$85.7K	0.02%	525
2024 Q2	–	Sell	-1,000	Closed	-$11.9K	–	1950
2024 Q1	$11.9K	Buy	+1,000	New	+$13.3K	﹤0.01%	1128

Other funds holding KALV

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Quarry LP's KALV Position: Q2 2026 in Review

Quarry LP sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 33,750 shares — an estimated $679K sold.

Quarry LP first reported a position in KALV in Q1 2024 and held it in 4 quarters. The position peaked at $679K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Quarry LP reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Quarry LP sold 33,750 KalVista Pharmaceuticals shares in Q2 2026, an estimated $679K.
Quarry LP first reported a position in KalVista Pharmaceuticals in Q1 2024 and held it in 4 quarters.
Quarry LP's KalVista Pharmaceuticals position peaked at $679K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.